<?xml version="1.0" encoding="UTF-8"?>
<p>Some studies also questioned the use of anti-ACE2 antibodies to inhibit viral replication of SARS-CoV. These could possibly inhibit virus-induced cytopathicity in a dose-dependent manner.
 <sup>
  <xref rid="bibr32-0004563220928361" ref-type="bibr">32</xref>
 </sup>
</p>
